Fatigue, frequently encountered in medical practice, often presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing fatigue, thereby enhancing patient care.
Fatigue is a common complaint, yet it often remains underdiagnosed due to its subjective nature and the absence of specific diagnostic tests. It can be a symptom of various underlying conditions, including anemia, thyroid disorders, sleep disorders, mental health issues, and chronic illnesses such as cancer or heart disease.
A thorough history and physical examination are essential for diagnosing fatigue. Clinicians should evaluate the duration, severity, and impact of fatigue on daily activities. Additionally, the presence of other symptoms such as weight loss, fever, or pain might indicate a specific underlying condition. Laboratory tests, including complete blood count, thyroid function tests, and sleep studies, can also be helpful.
Management of fatigue should be tailored to the underlying cause. For instance, treatment of anemia or hypothyroidism often results in significant improvement. In cases of chronic fatigue syndrome or fibromyalgia, a multidisciplinary approach involving cognitive-behavioral therapy, graded exercise therapy, and pharmacological treatment can be beneficial. Lifestyle modifications, including regular exercise, a balanced diet, and adequate sleep, are also crucial.
Addressing fatigue in medical practice requires a comprehensive approach, encompassing careful assessment, appropriate diagnostic testing, and tailored management strategies. By recognizing and effectively managing fatigue, healthcare professionals can significantly improve patients' quality of life and overall health outcomes.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation